All In Biotech

Free tool

FAERS Monitor: Prograf

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050709 or its brand name (Prograf, Tacrolimus). Reports on generic versions are filed under their own applications.

Reports

155,512

Serious

139,657

90% of reports

Hospitalization

62,496

Death reported

25,602

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use15,345
  • drug ineffective10,482
  • product use in unapproved indication6,396
  • drug interaction6,373
  • acute kidney injury6,111
  • diarrhoea5,893
  • transplant rejection4,902
  • death4,875
  • pyrexia4,864
  • cytomegalovirus infection4,599
  • pneumonia4,567
  • toxicity to various agents3,914
  • covid-193,893
  • renal impairment3,617
  • sepsis3,580

Reports by year received

View as table
YearReports
2004699
2005875
2006913
20071,485
20081,997
20092,169
20102,343
20113,918
20124,663
20133,853
20144,552
20155,030
20166,022
20178,087
201810,994
201910,666
202012,133
202111,473
202211,897
202313,254
202414,306
202514,189
20269,986

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,898,647 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
transplant rejectionSignal4,902211.1201.9398,814
cytomegalovirus infectionSignal4,59951.349.6164,349
renal impairmentSignal3,6176.05.814,611
drug interactionSignal6,3735.65.523,396
acute kidney injurySignal6,1115.65.422,234
sepsisSignal3,5804.54.39,320
product use in unapproved indicationSignal6,3963.63.511,584
toxicity to various agentsSignal3,9143.23.15,792
covid-19Signal3,8933.03.05,275
off label useSignal15,3452.42.412,775
pneumonia4,5671.91.92,018
pyrexia4,8641.91.92,127
diarrhoea5,8931.21.2273
drug ineffective10,4821.11.160
death4,8750.80.7368

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.